Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Non Operating Income (2022 - 2025)

Historic Non Operating Income for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $317560.0.

  • CervoMed's Non Operating Income fell 5059.22% to $317560.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 655.49%. This contributed to the annual value of $1.9 million for FY2024, which is 6567.22% down from last year.
  • According to the latest figures from Q3 2025, CervoMed's Non Operating Income is $317560.0, which was down 5059.22% from $357871.0 recorded in Q2 2025.
  • CervoMed's 5-year Non Operating Income high stood at $4.8 million for Q3 2023, and its period low was -$620059.0 during Q4 2022.
  • For the 4-year period, CervoMed's Non Operating Income averaged around $618877.2, with its median value being $357871.0 (2025).
  • Its Non Operating Income has fluctuated over the past 5 years, first surged by 2241640.61% in 2023, then tumbled by 9096.36% in 2024.
  • CervoMed's Non Operating Income (Quarter) stood at -$620059.0 in 2022, then soared by 119.04% to $118052.0 in 2023, then surged by 353.11% to $534907.0 in 2024, then tumbled by 40.63% to $317560.0 in 2025.
  • Its last three reported values are $317560.0 in Q3 2025, $357871.0 for Q2 2025, and $408850.0 during Q1 2025.